Target intelligence / Profile preview

Vibrio cholerae surface antigens (V. cholerae antigens)

Target
V. cholerae antigens
Molecular classification
Bacterial surface protein, Antigen, Adhesin
01

Overview

Vibrio cholerae surface antigens, including flagellin and various outer membrane proteins, are the primary targets for prophylactic vaccines against cholera. Flagellin, particularly the FlaA subunit, is the major component of the bacterial flagellum and is essential for the motility and chemotaxis required for the pathogen to penetrate the mucus layer of the small intestine (UniProt P0C6C7). Other critical surface proteins, such as the toxin-coregulated pilus (TCP) and outer membrane protein U (OmpU), facilitate the adherence and colonization of the intestinal epithelium (PubMed: 11004594). When these antigens are presented to the host via oral vaccines, they stimulate the production of secretory IgA and systemic vibriocidal antibodies. These immune components neutralize the pathogen by blocking its ability to move and attach to host cells, thereby preventing the subsequent release of cholera toxin and the development of severe secretory diarrhea (WHO Cholera Vaccines Position Paper). Current therapeutic strategies focus on using inactivated whole-cell preparations or recombinant subunits to provide broad protection against various serogroups, primarily O1 and O139 (CDC Yellow Book).

Other names
Vibrio cholerae flagellinFlaAOuter membrane protein U (OmpU)Toxin-coregulated pilus (TCP)Vibrio cholerae surface protein antigensBacterial flagellar filament protein
02

Mechanism of action

Induction of active mucosal and systemic immunity; stimulation of secretory IgA and serum vibriocidal antibodies that inhibit bacterial motility and attachment to the intestinal mucosa.

03

Biological functions

Bacterial motilityCell adhesionColonizationImmune response inductionChemotaxis
04

Disease associations

InfectionCholera
05

Safety considerations

Mild gastrointestinal symptoms (nausea, cramping)Short-term duration of immunityReduced efficacy in children under 5 years oldPotential for lower immune response in individuals with blood group O
06

Interacting drugs

Dukoral

4 more in the full profile.

07

Biomarkers

Vibriocidal antibody titerAnti-LPS IgAAnti-flagellin IgG

Beyond the preview

Go deeper on Vibrio cholerae surface antigens (V. cholerae antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrio cholerae surface antigens (V. cholerae antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call